Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangjianchen Xu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biometrics|February 16, 2024
Proportional rates models for multivariate panel count dataYangjianchen Xu, Donglin Zeng, Dan-Yu Lin
Biometrika|August 21, 2023
Marginal proportional hazards models for multivariate interval-censored dataYangjianchen Xu, Donglin Zeng, D Y Lin
Journal of the American Statistical Association|December 8, 2025
Checking the Cox Proportional Hazards Model with Interval-Censored DataYangjianchen Xu, Donglin Zeng, D Y Lin
Journal of Biotechnology and Biomedicine|December 5, 2023
A Cost-Benefit Analysis of Bivalent Covid-19 VaccinesDan-Yu Lin, Yangjianchen Xu, Donglin Zeng, et al.
JAMA Internal Medicine|October 27, 2025
Durability of 2024-2025 COVID-19 Vaccines Against JN.1 SubvariantsYi Du, Sai Paritala, Yangjianchen Xu, et al.
The New England Journal of Medicine|April 12, 2023
Durability of Bivalent Boosters against Omicron SubvariantsDan-Yu Lin, Yangjianchen Xu, Yu Gu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 5, 2024
Impact of booster vaccination interval on SARS-CoV-2 infection, hospitalization, and deathDan-Yu Lin, Yangjianchen Xu, Yu Gu, et al.
The New England Journal of Medicine|May 29, 2024
Durability of XBB.1.5 Vaccines against Omicron SubvariantsDan-Yu Lin, Yi Du, Yangjianchen Xu, et al.
The Lancet. Infectious Diseases|June 19, 2023
Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort studyDan-Yu Lin, Yangjianchen Xu, Yu Gu, et al.
JAMA|September 26, 2022
Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 OutcomesDan-Yu Lin, Yu Gu, Yangjianchen Xu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biometrics|February 16, 2024
Proportional rates models for multivariate panel count dataYangjianchen Xu, Donglin Zeng, Dan-Yu Lin
Biometrika|August 21, 2023
Marginal proportional hazards models for multivariate interval-censored dataYangjianchen Xu, Donglin Zeng, D Y Lin
Journal of the American Statistical Association|December 8, 2025
Checking the Cox Proportional Hazards Model with Interval-Censored DataYangjianchen Xu, Donglin Zeng, D Y Lin
Journal of Biotechnology and Biomedicine|December 5, 2023
A Cost-Benefit Analysis of Bivalent Covid-19 VaccinesDan-Yu Lin, Yangjianchen Xu, Donglin Zeng, et al.
JAMA Internal Medicine|October 27, 2025
Durability of 2024-2025 COVID-19 Vaccines Against JN.1 SubvariantsYi Du, Sai Paritala, Yangjianchen Xu, et al.
The New England Journal of Medicine|April 12, 2023
Durability of Bivalent Boosters against Omicron SubvariantsDan-Yu Lin, Yangjianchen Xu, Yu Gu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 5, 2024
Impact of booster vaccination interval on SARS-CoV-2 infection, hospitalization, and deathDan-Yu Lin, Yangjianchen Xu, Yu Gu, et al.
The New England Journal of Medicine|May 29, 2024
Durability of XBB.1.5 Vaccines against Omicron SubvariantsDan-Yu Lin, Yi Du, Yangjianchen Xu, et al.
The Lancet. Infectious Diseases|June 19, 2023
Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort studyDan-Yu Lin, Yangjianchen Xu, Yu Gu, et al.
JAMA|September 26, 2022
Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 OutcomesDan-Yu Lin, Yu Gu, Yangjianchen Xu, et al.
Pageof 2